Déjà vu? MHRA reviews kava
This article was originally published in The Tan Sheet
Executive Summary
The Medicines & Healthcare products Regulatory Agency will conduct a formal 12-week "public consultation exercise" in January 2005 to assess "whether the controls on kava kava remain justified and proportionate" and to "review the evidence relating to the hepatotoxicity" of the herbal, the UK health agency announces Aug. 11. The ban on kava in unlicensed herbal medicines took effect in January 2003 following reports of liver damage associated with the ingredient's consumption (1"The Tan Sheet" Jan. 6, 2003, In Brief). Health ministers who prohibited kava's sale requested the two-year follow-up. MHRA will formally write to interest groups for comment in January...